The residency is a 52-week, ASHP-accredited, post-graduate program that
begins around July 1 annually. We accept one resident yearly. Application
deadline is Jan. 15. Early commit for UKKD PGY1 resident available.
Other elective learning experiences may be developed based on resident
interest and preceptor availability.
PGY2 SAMPLE SCHEDULE
PROGRAM COMPLETION REQUIREMENTS
Attain an “achieved for residency” (ACHR) on 95% of the objectives
as assessed by the RPD on the last quarterly evaluation.
100% of the Patient Care (R1) objectives must be marked ACHR.
In order to successfully complete the program, no areas should be marked
as “needs improvement” (NI) by the residency end date.
Complete a yearlong research project [major project].
Submit a project for presentation at the Making a Difference in Infectious
Diseases (MAD-ID) meeting or alternative as agreed upon by resident and
Residency Program Director and/or Residency Advisory Committee.
Complete a manuscript suitable for publication and receive approval from
the project preceptor(s) and Residency Program Director.
Complete a midyear research project [minor project].
Submit project for presentation at the ASHP Midyear Clinical Meeting.
Develop one of the annual antibiograms and update related treatment guidelines.
Document coverage of all required topics from the PGY2 ID topic list (see
Appendix 1).
De-identified ivents, topic discussions, and any other applicable items
will be added to PharmAcademic.
Prepare and present two (2) ACPE or equivalent education sessions.
Attend required professional meetings:
ASHP Midyear Clinical Meeting
Making a Difference in Infectious Diseases (or alternative ID/residency
conference as determined by annual review)
Extenuating circumstances (death in the family, severe illness, global
pandemic) may preclude the resident from fulfilling specifically timed
requirements, e.g., professional meetings. In such instances, an alternative
will be substituted, as agreed upon by the resident and Residency Program
Director and/or Residency Advisory Committee
Participate in the recruitment efforts of the program.
Residents are expected to attend and actively participate in recruitment
events to which they are assigned.
Participate in teaching certificate program if not completed during PGY1
(offered through Marshall University School of Pharmacy).
Participate in four (4) professional/community service events.
Prepare and participate in P&T Committee meeting presentations.
Participate in Antimicrobial Stewardship (ASC), Diagnostic Stewardship
(DxSt), and Infection Control committee meetings.
Complete a minimum of 30 staffing shifts throughout the residency year.
Complete all assigned PharmAcademic evaluations.
Other responsibilities may arise during the residency year. The Residency
Program Director and the resident will discuss these as they arise.
STAFFING REQUIREMENTS (EVERY THIRD WEEKEND)
Verification of antimicrobial orders
Interventions to improve antimicrobial selection and dose optimization
Antimicrobial stewardship activities
STIPEND
PGY2: $57,528
PGY2 INFECTIOUS DISEASES RESIDENT 2025-26
Ashton Rexroad, PharmD
Dr. Rexroad is the current PGY-2 infectious diseases pharmacy resident
at UK King's Daughters Medical Center in Ashland, Ky. She is a 2024 graduate
of Marshall University School of Pharmacy and completed her PGY-1 pharmacy
practice residency at St. Mary's Medical Center located in Huntington,
WV. Dr. Rexroad's current practice interests include antimicrobial stewardship,
medication safety, and public health.
Upon completion of PGY-2, she plans to work as a clinical pharmacy specialist
in infectious diseases and antimicrobial stewardship with an emphasis
in transitions of care.